MetLife, Inc.

Valuation Analysis

About the Company

MetLife, Inc. en bref

MetLife, Inc. (MET) is currently trading at 74,61 € with a market capitalization of 48,0 Md €. The trailing P/E ratio stands at 16.55x, with a forward P/E of 7.78x. The 52-week range spans from 58,70 € to 78,13 €; the current price is 4.5% below the yearly high. Year-over-year revenue growth stands at +2.7%. The net profit margin stands at 4.67%.

💰 Dividende

MetLife, Inc. pays an annual dividend of 2,07 € per share, representing a yield of 2.77%. The payout ratio stands at 43.91%.

📊 Avis des analystes

16 analystes évaluent MetLife, Inc. (MET) au consensus : Acheter. L'objectif de cours moyen est de 80,20 €, soit un potentiel de +7.5% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 65,38 € à 92,41 €.

MetLife, Inc. : la thèse d'investissement en détail

MetLife, Inc. (MET) operates in the Financial Services — specifically Insurance - Life — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 35.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 2.7%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 4.67%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

With a PEG ratio of 0.46, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 7.78x is meaningfully below the trailing 16.55x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy MetLife, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.